首页> 美国卫生研究院文献>Annals of Translational Medicine >AB141. Multiplex PCR-based procedure establishment for simultaneous detection of two mutations occurring most frequently in FMS-like tyrosine kinase-3
【2h】

AB141. Multiplex PCR-based procedure establishment for simultaneous detection of two mutations occurring most frequently in FMS-like tyrosine kinase-3

机译:AB141。基于多重PCR的程序建立用于同时检测FMS样酪氨酸激酶-3中最频繁出现的两个突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute myeloid leukemia (AML) is a hematological disorder strongly correlated to several gene mutations which have been used in diagnosis and prognosis of disease. FMS-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase, involving in cell differentiation and proliferation. In AML, abnormal haematopoietic cells carry most commonly two FLT3 mutations, namely internal tandem duplication (ITD) and tyrosine kinase domain (TKD) found in approximately 25% and 5% among patients, respectively. Previously, two separate PCR based procedures was widely used to detect two mutations. In this study, we established a detection procedure for both mutations consisted of two major steps: multiplex PCR for simultaneous amplification of a 329 base-pair amplicon for ITD containing region and a 146 bp amplicon for TKD prone region, and digestion of the PCR products with EcoRV followed by analysis on 8% polyarylamide gel. The procedure was performed with previously confirmed ITDwt/TKDwt, ITDmt/TKDwt, and ITDwt/TKDmt samples and showed consistency with earlier result obtained by using separate procedures for each mutations. Moreover, the procedure is rapid, consuming 6 hours compared to 10 hours and more effective, using less reagents for PCR and polyacrylamide electrophoresis in detection of two mutants. In conclusion, we successfully established more productive multiplex PCR-based method for detection of two common AML-related mutations in FLT3 gene.
机译:急性髓细胞性白血病(AML)是一种血液疾病,与几种已在疾病的诊断和预后中使用的基因突变密切相关。 FMS样酪氨酸激酶3(FLT3)是一种受体酪氨酸激酶,参与细胞分化和增殖。在AML中,异常造血细胞最常携带两个FLT3突变,即内部串联重复(ITD)和酪氨酸激酶结构域(TKD),分别在患者中约占25%和5%。以前,两个基于PCR的单独程序被广泛用于检测两个突变。在这项研究中,我们建立了两个突变的检测程序,包括两个主要步骤:多重PCR,同时扩增ITD含区的329个碱基对的扩增子和TKD易感区的146 bp的扩增子,以及PCR产物的消化用EcoRV,然后在8%聚芳基酰胺凝胶上进行分析。该程序使用先前确认的ITDwt / TKDwt,ITDmt / TKDwt和ITDwt / TKDmt样品进行,显示出与通过对每个突变使用单独的程序获得的较早结果一致。而且,该过程快速,与10小时相比,耗时6小时,更有效,在检测两个突变体时使用较少的PCR和聚丙烯酰胺电泳试剂。总之,我们成功地建立了基于生产力更高的基于多重PCR的方法来检测FLT3基因中两个常见的AML相关突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号